May 6 |
Agenus Q1 2024 Earnings Preview
|
May 1 |
Agenus regains compliance with Nasdaq minimum bid price requirement
|
May 1 |
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
Apr 30 |
Time Is Running Out For Agenus To Raise Cash
|
Apr 28 |
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
|
Apr 24 |
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
|
Apr 23 |
Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month
|
Apr 23 |
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
|
Apr 22 |
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
|
Apr 12 |
Agenus reports updated Phase 1 data on colorectal cancer therapy
|